Sanofi, Takeda announce CFO changes as part of earnings releases
Both drugmakers made financial leadership changes and released their respective latest earnings reports.
Source: mmm-online.com
Launch Products News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Launch Products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Launch Products Today - Breaking & Trending Today
Takeda Announces ThirdQuarter FY2023 Results OnTrack Towards FullYear Management Guidance With Strong Momentum in Growth Launch Products
Takeda TOKYO4502NYSETAK today announced financial results for the third quarter of fiscal year 2023 period ended December 31 2023. With yeartodate strong momentum in its Growth Launch Products 12.7 at CER offsetting the significant revenue impact of generic entrants Takeda remains on track towards its fullyear Management Guidance.
Source: businesswireindia.com
Takeda Announces Third-Quarter FY2023 Results; On-Track Towards Full-Year Management Guidance With S
Two New U.S. FDA Approvals in FY2023 Q3: FRUZAQLA for Adults With Previously Treated Metastatic Colorectal Cancer and ADZYNMA for Ultra-Rare Blood Clotting Disorder cTTPStrong Commercial Execution Maximizing Value of Existing Portfolio:ENTYVIO® Pen Launched in U.S. for Ulcerative Colitis; U.S. FDA Approval Decision...
Source: pharmiweb.com
Why Is Japanese Drugmaker Takeda Stock Trading Lower Today? - Takeda Pharmaceutical (NYSE:TAK)
Takeda Pharmaceutical's Q3 2023 results: ¥235.9 billion core net profit, management changes, and a global collaboration deal for rusfertide. Fiscal year 2023 guidance reiterated.
Source: benzinga.com
Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
26.10.2023 - Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the first half of fiscal year 2023 (six months ended September 30, 2023), updating reported and Core forecasts and reconfirming Management Guidance for Core change at CER. Takeda ...
Source: wallstreet-online.de